Galapagos NV
GLPG
#4552
Rank
HK$16.35 B
Marketcap
HK$248.18
Share price
-0.69%
Change (1 day)
22.87%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -HK$2.52

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -HK$2.65. In 2024 the company made an earnings per share (EPS) of HK$9.12 a decrease over its 2023 EPS that were of HK$27.77.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.52-127.63%
2024HK$9.12-67.16%
2023HK$27.77-199.64%
2022-HK$27.8799.03%
2021-HK$14.00-68.98%
2020-HK$45.15-298.06%
2019HK$22.80-554.64%
2018-HK$5.01-77.18%
2017-HK$21.97-326.21%
2016HK$9.71-134.19%
2015-HK$28.41-371.34%
2014HK$10.47-445.98%
2013-HK$3.0332.88%
2012-HK$2.28-82.07%
2011-HK$12.70-817.9%
2010HK$1.7712.73%
2009HK$1.57-120.79%
2008-HK$7.55-37.67%
2007-HK$12.1139.64%
2006-HK$8.6728.17%
2005-HK$6.776.25%
2004-HK$6.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.17-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.34-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.72-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.16-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$57.19-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$41.87-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$29.49-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-HK$4.77 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$9.70-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel